Shelf life – Page 33

Why Shelf-Life Extension Fails When Original Study Design Is Weak

Addressing Failures in Shelf-Life Extensions Due to Weak Study Design Pharmaceutical manufacturers often face challenges in shelf-life extensions when the original stability study design is flawed. Missteps in designing these…

Why Shelf-Life Extension Fails When Original Study Design Is Weak

Addressing Failures in Shelf-Life Extension Due to Weak Study Design In the highly regulated pharmaceutical industry, robust stability study design is paramount for determining the shelf-life of products. A common…

Stability Commitments for First Commercial Batches After Approval

Addressing Regulatory Expectations for Stability Studies in First Commercial Batches In the complex landscape of pharmaceutical manufacturing, ensuring that first commercial batches meet regulatory expectations for stability is a significant…

Photostability Study Risk Assessment for New Product Development

Assessing Risks in Photostability Studies for New Pharmaceutical Products In the realm of pharmaceutical development, photostability studies are critical for ensuring that products maintain their quality and efficacy when exposed…

Stability Study Design Problems in Outsourced Testing Programs

Addressing Challenges in Stability Study Design for Outsourced Testing Programs Stability study design errors can have far-reaching implications for pharmaceutical products, potentially leading to compromised product quality and regulatory non-compliance.…

How to Address Regulator Concerns on Limited Long-Term Stability Data

Addressing Regulatory Concerns Regarding Limited Long-Term Stability Data As pharmaceutical professionals, we often encounter regulatory inquiries about the robustness of long-term stability data for our products. Regulatory agencies emphasize the…

How to Align Photostability Study Conditions with Global Filing Requirements

Aligning Photostability Study Conditions with Global Filing Requirements Photostability study failures can have significant implications for regulatory compliance and product shelf-life management. If your laboratory has encountered discrepancies in photostability…

How to Align Stability Protocols with CTD Module 3 Expectations

Aligning Stability Protocols with CTD Module 3 Expectations: A Comprehensive Troubleshooting Guide In the pharmaceutical manufacturing landscape, misalignment of stability protocols with ICH CTD Module 3 requirements can lead to…

Regulatory Expectations for Stability Data in Variation and Supplement Filings

Understanding Regulatory Requirements for Stability Data in Variation and Supplement Filings In the pharmaceutical landscape, adherence to regulatory expectations for stability studies plays a crucial role in maintaining product quality…

Photostability Failures in Multidose Containers: In-Use Light Exposure Risks

Addressing Photostability Failures in Multidose Containers: Understanding In-Use Light Exposure Risks Organizations involved in pharmaceutical manufacturing must remain vigilant regarding photostability study failures, particularly when dealing with multidose containers. When…

Stability Design Errors in Photolabile Drug Products

Addressing Design Flaws in Stability Studies for Photolabile Drug Products Stability study design errors are a persistent challenge in the pharmaceutical industry, particularly for photolabile drug products. These errors can…

How to Create a Regulatory-Ready Stability Master Plan

Establishing a Compliance-Ready Stability Master Plan In the pharmaceutical industry, constructing a robust Stability Master Plan (SMP) is critical for meeting regulatory expectations for stability studies. This article will guide…